Key Events This Week
10 Aug: Stock opens at Rs.0.53, declines 1.85%
12 Aug: Hits 52-week low and all-time low at Rs.0.51-0.52
14 Aug: Week closes at Rs.0.52, unchanged from previous close

Shree Ganesh Biotech India Ltd Extends Losing Streak, Hits All-Time Low Amidst Financial Struggles
2026-08-12 11:17:25For the sixth consecutive session, Shree Ganesh Biotech India Ltd closed lower, touching a fresh all-time low of Rs 0.52 on 12 Aug 2026. This marks a continuation of a steep decline that has seen the stock lose 35.0% over the past year, significantly underperforming the Sensex's modest 3.25% fall during the same period.
Read full news articleAre Shree Ganesh Biotech India Ltd latest results good or bad?
2026-08-05 19:25:09Shree Ganesh Biotech India Ltd's latest financial results reflect a challenging operational landscape. In the fiscal year 2025, the company reported net sales of ₹22.00 crores, which represents a modest year-on-year growth of 10.0% from ₹20.00 crores in FY24. However, this growth is overshadowed by significant operational difficulties, as the company incurred an operating loss of ₹1.00 crore, leading to a negative operating margin of 4.5%. This marks a troubling trend, as the company has transitioned from generating operating profits in previous years to facing losses. The financial trajectory over the past few years reveals extreme volatility in revenues, with a dramatic decline from ₹72.00 crores in FY22 to ₹20.00 crores in FY24, before a slight recovery in FY25. This pattern suggests underlying instability rather than cyclical fluctuations. Additionally, the company's return on equity has fallen to 0.80...
Read full news article
Shree Ganesh Biotech India Q1 FY27: Mounting Losses Deepen Financial Crisis
2026-08-04 22:31:47Shree Ganesh Biotech India Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹22.00 crores, continues to struggle with operational profitability as the company posted operating losses in Q1 FY27. Trading at ₹0.55 per share as of August 4, 2026, the stock has witnessed a precipitous decline of 30.38% over the past year, substantially underperforming the Sensex which declined 3.20% during the same period. With zero promoter holding, minimal institutional interest at 1.42%, and a concerning "Strong Sell" rating with a score of just 12 out of 100, the company faces mounting challenges in an already competitive pharmaceutical sector.
Read full news article
Shree Ganesh Biotech India Ltd Slides to All-Time Low Amid Prolonged Downtrend
2026-07-30 09:35:07The stock of Shree Ganesh Biotech India Ltd has reached a fresh all-time low of Rs.0.52 on 30 Jul 2026, extending a multi-year decline that has seen the share price lose over 90% of its value in the past five years. Despite some recent upticks in profitability, the share price continues to reflect significant investor caution.
Read full news article








